相关实验视频
Updated: Jan 16, 2026

08:53
Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
15.9K
预测全源造血干细胞移植接受者的心血管事件
Benjamin Sibilia1,2,3, Trecy Gonçalves1,2,3, Florian Chevillon4
1Université Paris Cité, Service de Cardiologie, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, 75010, Paris, France.
European journal of preventive cardiology
|September 30, 2025
概括
鉴定了所有原性干细胞移植后心血管并发症的预测因素. 关键因素包括年龄,高血压和先前的心力衰竭,告知早期和晚期事件风险分层.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 所有性造血干细胞移植 (alloHSCT) 患者面临显著的心血管风险.
- 在大型alloHSCT队列中对这些风险的综合数据有限.
研究的目的:
- 在大量alloHSCT患者中确定心血管事件的预测因子.
- 为了区分早期与晚期心脏毒性的预测因素.
主要方法:
- 从2011年到2020年,对1027名aloHSCT患者 (≥15年) 的回顾性单心研究.
- 从电子病历中提取的数据.
- 心脏毒性 (心血管死亡,心力衰竭,心律失常,动脉/静脉事件,心肌炎) 分析使用考克斯回归和细灰模型.
主要成果:
- 30%的患者在4年的中位数随访期内出现心脏毒性.
- 早期事件预测因素 (≤100天):年龄,高血压,心力衰竭史,与癌症治疗相关的心脏功能障碍 (CTRCD),高剂量环胺.
- 晚期事件预测指标 (>100天):年龄,高血压,静脉血栓栓塞 (VTE) 史,心房动/动,HF史,CTRCD,人环素暴露,高风险HCT-CI得分.
结论:
- 已经确定了早期和晚期心脏毒性后alloHSCT的独立预测因素.
- 这些预测因素包括人口统计数据,心血管风险因素和瘤病史.
更多相关视频
相关概念视频
Bone Marrow Sampling and Transplants
886
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
886
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K

